ADAP

Adaptimmune Therapeutics plc ADAP

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ADAP NCNA CANF KZIA BDRX EVAX ATHE PPBT BPTSY AKTX
6M -18.49 % -96.07 % -67.51 % 81.52 % -55.20 % 362.64 % 47.04 % -75.60 % -58.93 % -12.13 %
YTD -70.94 % -97.63 % -71.50 % -20.13 % -80.61 % 35.19 % 23.78 % -86.71 % -55.34 % -22.30 %
1Y -79.39 % -98.47 % -79.76 % -65.32 % -84.84 % -53.56 % 269.35 % -85.12 % -66.67 % -64.65 %
3Y -83.82 % -99.89 % -93.09 % -86.81 % -99.99 % -95.52 % 0.37 % -98.46 % -99.34 % -90.98 %
5Y -98.03 % -99.98 % -97.29 % -97.68 % -100.00 % -98.74 % -77.26 % -99.31 % -99.98 % -97.55 %
10Y -97.72 % -99.99 % -99.92 % -98.65 % -100.00 % -98.74 % -90.95 % -99.90 % -99.98 % -99.74 %
From the beginning -98.87 % -99.99 % -99.94 % -99.73 % -100.00 % -98.74 % -99.32 % -99.90 % -99.98 % -99.71 %

Dividend